MIT

Researchers hope the system can zero in on the right patients to enroll in clinical trials, to speed discovery of drug treatments. A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up …